serine (or cysteine) peptidase inhibitor, clade A, member 5
| GO Term | Evidence Code | PMID |
|---|---|---|
| spermatogenesis | ||
| negative regulation of peptidase activity |
|
|
| negative regulation of proteolysis | ||
| negative regulation of proteolysis | ||
| negative regulation of hydrolase activity |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein C inhibitor-coagulation factor V complex | ||
| protein C inhibitor-coagulation factor Xa complex | ||
| protein C inhibitor-coagulation factor Xa complex | ||
| protein C inhibitor-coagulation factor XI complex | ||
| protein C inhibitor-coagulation factor XI complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| retinoic acid binding | ||
| retinoic acid binding | ||
| protease binding | ||
| protease binding | ||
| serine-type endopeptidase inhibitor activity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026